These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9370197)

  • 1. Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit.
    Micevych PE; Eckersell CB; Brecha N; Holland KL
    Brain Res Bull; 1997; 44(4):335-43. PubMed ID: 9370197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate receptors modulate estrogen-induced cholecystokinin and tachykinin but not enkephalin messenger RNA levels in the limbic system and hypothalamus.
    Eckersell CB; Micevych PE
    Neuroscience; 1997 Sep; 80(2):473-85. PubMed ID: 9284350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of CCK-A receptor mRNA antisense oligodeoxynucleotides inhibits lordosis behavior.
    Holland KL; Popper P; Micevych PE
    Physiol Behav; 1997 Sep; 62(3):537-43. PubMed ID: 9272661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripubertal ontogeny and estrogen stimulation of cholecystokinin and preproenkephalin mRNA in the rat hypothalamus and limbic system.
    Holland KL; Norby LA; Micevych PE
    J Comp Neurol; 1998 Mar; 392(1):48-57. PubMed ID: 9482232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CCK mRNA levels in the limbic-hypothalamic circuit: time course and site-specific effects of estrogen.
    Micevych P; Eckersell CB; Holland K; Smith A
    J Neurobiol; 1996 Aug; 30(4):465-79. PubMed ID: 8844510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
    Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
    J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced alteration of mu-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala.
    Eckersell CB; Popper P; Micevych PE
    J Neurosci; 1998 May; 18(10):3967-76. PubMed ID: 9570823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the limbic-hypothalamic cholecystokinin circuit: a model of sexual differentiation.
    Micevych P; Ulibarri C
    Dev Neurosci; 1992; 14(1):11-34. PubMed ID: 1600878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.
    Smadja C; Ruiz F; Coric P; Fournié-Zaluski MC; Roques BP; Maldonado R
    Psychopharmacology (Berl); 1997 Aug; 132(3):227-36. PubMed ID: 9292622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of thyroxine and estrogen on the expression of estrogen receptor alpha, cholecystokinin, and preproenkephalin messenger ribonucleic acid in the limbic-hypothalamic circuit.
    Holland K; Norell A; Micevych P
    Endocrinology; 1998 Mar; 139(3):1221-8. PubMed ID: 9492057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and endogenous opioids regulate CCK in reproductive circuits.
    Micevych P; Sinchak K
    Peptides; 2001 Aug; 22(8):1235-44. PubMed ID: 11457516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medial preoptic area delta-opioid receptors inhibit lordosis.
    Sinchak K; Mills RH; Eckersell CB; Micevych PE
    Behav Brain Res; 2004 Dec; 155(2):301-6. PubMed ID: 15364490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an intrahypothalamic injection of antisense oligonucleotides for preproenkephalin mRNA in female rats: evidence for opioid involvement in lordosis reflex.
    Nicot A; Ogawa S; Berman Y; Carr KD; Pfaff DW
    Brain Res; 1997 Nov; 777(1-2):60-8. PubMed ID: 9449413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.
    Roques BP; Noble F
    Neurochem Res; 1996 Nov; 21(11):1397-410. PubMed ID: 8947930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats.
    Acosta-Martinez M; Etgen AM
    Horm Behav; 2002 Feb; 41(1):88-100. PubMed ID: 11863387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal steroid control of preprocholecystokinin mRNA expression in the limbic-hypothalamic circuit: comparison of adult with neonatal steroid treatments.
    Micevych PE; Abelson L; Fok H; Ulibarri C; Priest CA
    J Neurosci Res; 1994 Jul; 38(4):386-98. PubMed ID: 7932871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinjection of cholecystokinin into the medial preoptic nucleus facilitates lordosis behavior in the female rat.
    Dornan WA; Bloch GJ; Priest CA; Micevych PE
    Physiol Behav; 1989 May; 45(5):969-74. PubMed ID: 2780882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization.
    Micevych PE; Rissman EF; Gustafsson JA; Sinchak K
    J Neurosci Res; 2003 Mar; 71(6):802-10. PubMed ID: 12605406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.
    Quesada A; Micevych P
    Brain Res; 2006 Feb; 1073-1074():316-20. PubMed ID: 16472782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadal steroid hormones and hypothalamic opioid circuitry.
    Hammer RP; Zhou L; Cheung S
    Horm Behav; 1994 Dec; 28(4):431-7. PubMed ID: 7729811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.